Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Chengdu, Sichuan, China

    Main Sales Markets: Central/South America,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    • Name: Human Rabies Immunoglobulin
    • Use within: 24 months
    • Specifications:
    1. 100IU/vial (100IU/ml, 1ml)
    2. 200IU/vial (100IU/ml, 2ml)
    3. 500IU/vial (100IU/ml, 5ml)
    • Approval number:
    1. 100IU/vial (100IU/ml, 1ml) - NMPA Approval No. S20053014
    2. 200IU/vial (100IU/ml, 2ml) - NMPA Approval No. S20053015
    3. 500IU/vial (100IU/ml, 5ml) - NMPA Approval No. S20053016
    • Indications:

    Used for the passive immunization of patients bitten or scratched by rabid or other mad animals.All patients suspected of exposure to rabies should be treated with both rabies vaccine and rabies immunoglobulin. If the patient has been vaccinated against rabies and has sufficient levels of rabies antibodies, only vaccination is required, without the use of this product.

Send your message to this supplier
  • From:
  • To:
    Grand Shuyang Life Sciences (Chengdu) Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service